Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy

Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, and lipid–polymer hybrid nanoparticles—have received particular interest in antica...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Ana Camila, Costa, Paulo C., Velho, Sérgia, Amaral, Maria Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864942/
https://www.ncbi.nlm.nih.gov/pubmed/36678845
http://dx.doi.org/10.3390/pharmaceutics15010216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864942/
https://www.ncbi.nlm.nih.gov/pubmed/36678845
http://dx.doi.org/10.3390/pharmaceutics15010216

Ejemplares similares